StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/307% below fair value
$0.85+0.03 (+3.77%)

Close on Nov 17, 2026Market cap $37.82MP/E –Yield –

Elutia price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Elutia's price to sales ratio was 2.5× on Nov 11, 2026, against 2.8× a year earlier. Over the last 5 years it ranged from 0.2× to 7.5×, with a median of 2.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.5×−0.6
2025Dec 31, 20253.1×−1.3
2024Dec 31, 20244.5×+3.2
2023Dec 29, 20231.3×+0.1
2022Dec 30, 20221.1×+0.9
2021Jan 29, 20210.2×+0.0
2020Dec 31, 20200.2×–

More Elutia figures

See a number that looks wrong?